Generic Industry Faces Consolidation As Indian Firms Look To Enter U.S.

The generic industry will face continued pricing pressure as Indian firms move into the U.S. market, ABN-AMRO Healthcare Banking Director Tommy Erdei told the Generic Pharmaceutical Association Sept. 19